Armistice Capital, LLC 13D and 13G filings for Rigel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 2:30 pm Purchase | 2023-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | Armistice Capital, LLC | 1,710,000 9.810% | 14,400 (+0.85%) | Filing |
| 2023-02-14 1:21 pm Purchase | 2022-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL | Armistice Capital, LLC | 1,695,600 9.810% | 1,695,600 (New Position) | Filing |